Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Mar 1;35(2):115-124.
doi: 10.1097/CCO.0000000000000931.

Early Detection of Cancers in the Era of Precision Oncology

Wan Ying Tan  1 , Anup Sharma  1 , Paromita Das  1 , Nita Ahuja  1   2   3
Affiliations
Review

Early Detection of Cancers in the Era of Precision Oncology

Wan Ying Tan et al. Curr Opin Oncol. .

Abstract

Purpose of review: The increasing global incidence of cancer demands innovative cancer detection modalities. The current population-based early cancer detection approaches focus on several major types of cancers (breast, prostate, cervical, lung and colon) at their early stages, however, they generally do not target high-risk individuals at precancerous stages.

Recent findings: Some cancers, such as pancreatic cancer, are challenging to detect in their early stages. Therefore, there is a pressing need for improved, accessible, noninvasive, and cost-effective early detection methods. Harnessing cell-free-based biomarker-driven strategies paves a new era of precision diagnosis for multicancer early detection. The majority of these tests are in the early stages and expensive, but these approaches are expected to become cost sensitive in the near future.

Summary: This review provides an overview of early cancer detection strategies, highlighting the methods, challenges, and issues to be addressed to revolutionize and improve global early cancer detection.

PubMed Disclaimer

References

    1. Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71:209–249.
    1. Bruni L, Serrano B, Roura E, et al. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis. Lancet Global Health 2022; 10:e1115–e1127.
    1. Soo WKW, Chan DNS, Law BMH, et al. Achieving equitable access to cancer screening services to reduce the cancer burden in the Asia-Pacific region: experience from Hong Kong. Lancet Reg Health West Pac 2022; 29:100587.
    1. Barlow WE, Beaber EF, Geller BM, et al. Evaluating screening participation, follow-up, and outcomes for breast, cervical, and colorectal cancer in the PROSPR consortium. J Natl Cancer Inst 2020; 112:238–246.
    1. Bretthauer M, Løberg M, Wieszczy P, et al. Effect of colonoscopy screening on risks of colorectal cancer and related death. N EnglJ Med 2022; 387:1547–1556.

Publication types